These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2286715)

  • 21. Botulinum toxins in dentistry--the new paradigm for masticatory muscle hypertonicity.
    Katz H
    Singapore Dent J; 2005 Dec; 27(1):7-12. PubMed ID: 16438262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of strabismus by injecting botulinum toxin A into the oculomotor muscles].
    Krzystkowa KM; Szpytma R; Madroszkiewicz A
    Klin Oczna; 1987 Oct; 89(10):446-8. PubMed ID: 3450959
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of calcium-channel antagonists on tardive dyskinesia and psychosis.
    Adler L; Duncan E; Reiter S; Angrist B; Peselow E; Rotrosen J
    Psychopharmacol Bull; 1988; 24(3):421-5. PubMed ID: 3153502
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propranolol-induced tardive dyskinesia in a patient with akathisia.
    Sandyk R
    Ann Neurol; 1985 Sep; 18(3):370. PubMed ID: 4051467
    [No Abstract]   [Full Text] [Related]  

  • 26. [30 years experience with haloperidol].
    Bandelow B; Müller P; Rüther E
    Fortschr Neurol Psychiatr; 1991 Aug; 59(8):297-321. PubMed ID: 1937339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal haloperidol therapy associated with dyskinesia in a newborn.
    Collins KO; Comer JB
    Am J Health Syst Pharm; 2003 Nov; 60(21):2253-5. PubMed ID: 14619120
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
    Leblhuber F; Reisecker F; Bengesser G
    Z Gerontol; 1987; 20(1):49-51. PubMed ID: 2883781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Haloperidol in the treatment of psychotic disorders in old age].
    Kobrzyńska E; Chachaj L
    Psychiatr Pol; 1982; 16(1-2):13-7. PubMed ID: 7146202
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of botulinum toxin for treatment of strabismus, a preliminary report.
    Walden PG; Biglan AW
    Trans Pa Acad Ophthalmol Otolaryngol; 1985; 37(2):136-42. PubMed ID: 4012825
    [No Abstract]   [Full Text] [Related]  

  • 31. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent temporomandibular joint dislocation treated with botulinum toxin: report of 3 cases.
    Martínez-Pérez D; García Ruiz-Espiga P
    J Oral Maxillofac Surg; 2004 Feb; 62(2):244-6. PubMed ID: 14762760
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial.
    Padberg M; de Bruijn SF; de Haan RJ; Tavy DL
    Cephalalgia; 2004 Aug; 24(8):675-80. PubMed ID: 15265057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin in therapy of craniocervical dystonia].
    Dressler D; Benecke R; Conrad B
    Nervenarzt; 1989 Jul; 60(7):386-93. PubMed ID: 2668776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment and treatment of drug-induced tremor.
    Goetz CG; Dysken MW; Klawans HL
    J Clin Psychiatry; 1980 Sep; 41(9):310-5. PubMed ID: 7410325
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of spasmodic dysphonia with botulinum toxin].
    Vilkman E; Laurikainen E; Marttila R
    Duodecim; 1995; 111(16):1546-51. PubMed ID: 9273263
    [No Abstract]   [Full Text] [Related]  

  • 39. [Abnormal movements of the larynx. Diagnostic approach and therapeutic perspectives].
    Angelard B; Feve A; Moine A; Fichaux P; Guillard A; Lacau St Guily J
    Ann Otolaryngol Chir Cervicofac; 1993; 110(3):125-8. PubMed ID: 8239331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The value of botulinum toxin injection in treatment of achalasia].
    Hoeft SF; Porschen R
    Z Gastroenterol; 2000 Jan; 38(1):133-5. PubMed ID: 10689751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.